iCrowdNewswire
Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Jul 20, 2018 6:56 AM ET

Future of Fertility Test Market


iCrowd Newswire - Jul 20, 2018

Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine & Saliva-based)), Mode of Purchase (OTC, Prescription), Application (Female, Male), End User (Home care, Fertility clinics, Hospital) – Global Forecast to 2023″, published by MarketsandMarkets™

 

Browse 71 market data Tables and 31 Figures spread through 140 Pages and in-depth TOC on “Fertility Test Market”

https://www.marketsandmarkets.com/Market-Reports/fertility-testing-devices-market-139945432.html

Early buyers will receive 10% customization on this report 

 

Fertility Test Market is expected to reach USD 583.1 million by 2023 from USD 411.8 million in 2018, at a CAGR of 7.2%. The major factors driving the growth of the Fertility Test Market include declining fertility rates across the globe, increasing first-time pregnancy age, introduction of advanced, user-friendly fertility monitors with high accuracy.

 

The ovulation predictor kits segment accounted for the largest share of the market by product in 2018 

 

The Fertility Test Market is segmented on the basis of product into ovulation predictor kits, fertility monitors, and male fertility testing products. The fertility monitors segment is further categorized into urine-based, saliva-based and other fertility monitors. The ovulation predictor kits segment commanded the largest share of the global Fertility Test Market in 2018. This is primarily due to their low cost and high efficacy, high preference for these products, ease of use, low cost as compared to fertility monitors, and easy OTC availability.

 

Non-Prescription/OTC based is expected to account for a larger share of the market by mode of purchase in 2018 

 

Based on the mode of purchase, the global Fertility Test Market is classified into segments prescription-based and non-prescription/OTC-based. The non-prescription/OTC-based segment is expected to account for a larger share of the Fertility Test Market in 2018 due to its inclination of patients towards self-monitoring of healthcare conditions, increasing initiatives by market players to spread awareness on fertility, easy availability, and use of fertility and ovulation monitors on e-commerce websites.

 

Ask for PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=139945432

 

North America is expected to dominate the Fertility Test Market during the forecast period. 

 

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the global Fertility Test Market during the forecast period (2018-2023). The large share can be attributed to the growing use of fertility monitoring devices for contraception and rising awareness about the benefits of ovulation monitors through social media, marketing campaigns, and e-commerce sites. In addition, the emergence of advanced easy-to-use fertility monitors with high accuracy is one of the key factors propelling the growth of the Fertility Test Market in North America.

The major players operating in the Fertility Test Market include SPD Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), and Prestige Brands Holdings, Inc. (US), among others.

 

Know more about the Fertility Test Market: 

https://www.marketsandmarkets.com/ResearchInsight/fertility-testing-devices-market.asp

Contact Information:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]






Keywords:    fertility test market

Tags:    Wire, Research Newswire, Press Release, Private Companies, North America, South America, United States, Latin America, English